Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation
- 1 January 2008
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 122 (1) , 117-123
- https://doi.org/10.1016/j.thromres.2007.09.002
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Toward Rational Fresh Frozen Plasma TransfusionAmerican Journal of Clinical Pathology, 2006
- Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based reviewTransfusion, 2005
- New anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarinBritish Journal of Pharmacology, 2005
- The Pharmacology and Management of the Vitamin K AntagonistsChest, 2004
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 2004
- A new oral anticoagulant: the 50-year challengeNature Reviews Drug Discovery, 2004
- Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatantBritish Journal of Haematology, 2004
- Reversal of Warfarin-Induced Excessive Anticoagulation with Recombinant Human Factor VIIa ConcentrateAnnals of Internal Medicine, 2002
- Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patientsBritish Journal of Haematology, 2002
- Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation.Journal of Clinical Investigation, 1988